| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,075 |
5,841 |
$729K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,556 |
4,365 |
$596K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,880 |
7,715 |
$560K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,641 |
6,529 |
$393K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,398 |
3,293 |
$387K |
| 70450 |
Computed tomography, head or brain; without contrast material |
832 |
812 |
$199K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
462 |
456 |
$192K |
| 80053 |
Comprehensive metabolic panel |
11,460 |
10,429 |
$187K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
817 |
803 |
$184K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
732 |
716 |
$137K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,190 |
1,163 |
$130K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
915 |
891 |
$129K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,019 |
981 |
$110K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
891 |
875 |
$91K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
360 |
359 |
$81K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,059 |
2,046 |
$73K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
582 |
564 |
$56K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,135 |
3,045 |
$51K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,107 |
4,066 |
$48K |
| 80061 |
Lipid panel |
4,161 |
4,130 |
$42K |
| 71046 |
Radiologic examination, chest; 2 views |
3,026 |
2,952 |
$38K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,661 |
2,636 |
$31K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
540 |
538 |
$28K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
717 |
707 |
$28K |
| 36415 |
Collection of venous blood by venipuncture |
12,052 |
11,064 |
$27K |
| 83880 |
|
479 |
443 |
$24K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
743 |
730 |
$23K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,097 |
2,074 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,103 |
1,038 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,455 |
8,666 |
$20K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
192 |
192 |
$20K |
| 99222 |
Initial hospital care, per day, moderate complexity |
208 |
195 |
$20K |
| 84439 |
|
2,440 |
2,422 |
$19K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
798 |
778 |
$19K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
248 |
234 |
$17K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,001 |
1,965 |
$16K |
| 12001 |
|
60 |
60 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,389 |
1,100 |
$16K |
| 82803 |
|
958 |
884 |
$15K |
| G0378 |
Hospital observation service, per hour |
40 |
39 |
$14K |
| 99201 |
|
144 |
140 |
$14K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,323 |
1,168 |
$14K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
245 |
244 |
$13K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
742 |
730 |
$13K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
392 |
97 |
$12K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
639 |
628 |
$11K |
| 82607 |
|
802 |
798 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,660 |
2,535 |
$9K |
| 81001 |
|
3,650 |
3,462 |
$9K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
13 |
13 |
$9K |
| 99223 |
Prolong inpt eval add15 m |
73 |
72 |
$8K |
| 84153 |
|
422 |
416 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,581 |
3,348 |
$7K |
| 81025 |
|
2,340 |
2,259 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
43 |
43 |
$6K |
| 90791 |
Psychiatric diagnostic evaluation |
40 |
40 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,934 |
2,789 |
$4K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
13 |
13 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
25 |
25 |
$4K |
| 85027 |
|
1,788 |
1,646 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
552 |
550 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
88 |
85 |
$3K |
| 82043 |
|
664 |
658 |
$3K |
| 84702 |
|
596 |
553 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
838 |
802 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
167 |
163 |
$3K |
| 0012A |
|
66 |
66 |
$3K |
| J1670 |
Injection, tetanus immune globulin, human, up to 250 units |
13 |
13 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
324 |
315 |
$2K |
| 82570 |
|
509 |
508 |
$2K |
| 85610 |
|
1,328 |
1,126 |
$2K |
| 99233 |
Prolong inpt eval add15 m |
45 |
27 |
$2K |
| 81003 |
|
2,575 |
2,502 |
$2K |
| 0011A |
|
71 |
71 |
$2K |
| 76536 |
|
92 |
91 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
123 |
122 |
$2K |
| 72100 |
|
185 |
184 |
$2K |
| 82746 |
|
165 |
165 |
$2K |
| 80162 |
|
107 |
106 |
$2K |
| 73630 |
|
598 |
590 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
1,735 |
1,645 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,962 |
2,225 |
$2K |
| 86803 |
|
168 |
166 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,805 |
1,635 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
14 |
$1K |
| 83735 |
|
1,134 |
993 |
$1K |
| 82728 |
|
91 |
90 |
$1K |
| 72110 |
|
75 |
75 |
$1K |
| 73030 |
|
182 |
178 |
$1K |
| 74018 |
|
303 |
292 |
$1K |
| 83690 |
|
1,990 |
1,827 |
$1K |
| 73130 |
|
491 |
482 |
$1K |
| 84484 |
|
2,083 |
1,766 |
$998.87 |
| 87186 |
|
504 |
489 |
$978.32 |
| 85730 |
|
674 |
640 |
$953.97 |
| 83540 |
|
196 |
195 |
$894.01 |
| 73610 |
|
469 |
456 |
$847.41 |
| 90715 |
|
39 |
39 |
$840.59 |
| 86901 |
|
46 |
45 |
$796.50 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,594 |
1,565 |
$775.13 |
| 83550 |
|
155 |
153 |
$696.46 |
| 76641 |
|
36 |
36 |
$683.70 |
| 85651 |
|
419 |
414 |
$645.94 |
| 84481 |
|
71 |
71 |
$625.99 |
| 84403 |
|
25 |
25 |
$615.94 |
| 86850 |
|
29 |
28 |
$612.44 |
| 86900 |
|
46 |
45 |
$531.67 |
| 87340 |
|
52 |
52 |
$501.46 |
| 73564 |
|
97 |
95 |
$490.04 |
| 87070 |
|
871 |
853 |
$410.17 |
| 82248 |
|
95 |
91 |
$397.07 |
| 85007 |
|
901 |
785 |
$342.36 |
| 86780 |
|
25 |
25 |
$290.49 |
| 83605 |
|
808 |
730 |
$254.95 |
| 73110 |
|
109 |
108 |
$219.35 |
| 86703 |
|
16 |
16 |
$199.22 |
| 83655 |
|
13 |
13 |
$194.35 |
| 80076 |
|
13 |
13 |
$184.41 |
| 73502 |
|
12 |
12 |
$170.51 |
| 86038 |
|
28 |
28 |
$137.88 |
| 87077 |
|
51 |
48 |
$133.95 |
| 87899 |
|
87 |
84 |
$121.90 |
| 96376 |
|
313 |
201 |
$116.00 |
| 82948 |
|
667 |
451 |
$113.69 |
| 87088 |
|
35 |
34 |
$107.44 |
| 82150 |
|
152 |
148 |
$102.61 |
| 86140 |
|
26 |
26 |
$102.53 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
353 |
277 |
$100.17 |
| 73562 |
|
13 |
12 |
$96.78 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
818 |
805 |
$60.36 |
| 85379 |
|
88 |
85 |
$50.90 |
| 87147 |
|
19 |
19 |
$24.77 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
93 |
83 |
$6.88 |
| 87420 |
|
31 |
31 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
51 |
50 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
59 |
27 |
$0.00 |